Matthew Pasch - 15 Nov 2023 Form 3 Insider Report for Burlington Stores, Inc. (BURL)

Role
Chief Human Resources Officer
Signature
/s/ Christopher Schaub, as attorney-in-fact for Matthew Pasch
Issuer symbol
BURL
Transactions as of
15 Nov 2023
Net transactions value
$0
Form type
3
Filing time
22 Nov 2023, 16:15:12 UTC
Next filing
05 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BURL Common Stock 7,140 15 Nov 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BURL Employee Stock Option (right to buy) 15 Nov 2023 Common Stock 282 $135.37 Direct F2
holding BURL Employee Stock Option (right to buy) 15 Nov 2023 Common Stock 478 $170.08 Direct F3
holding BURL Employee Stock Option (right to buy) 15 Nov 2023 Common Stock 728 $179.46 Direct F4
holding BURL Employee Stock Option (right to buy) 15 Nov 2023 Common Stock 577 $326.73 Direct F5
holding BURL Employee Stock Option (right to buy) 15 Nov 2023 Common Stock 994 $211.68 Direct F6
holding BURL Employee Stock Option (right to buy) 15 Nov 2023 Common Stock 66 $234.15 Direct F7
holding BURL Employee Stock Option (right to buy) 15 Nov 2023 Common Stock 1,390 $186.61 Direct F8
holding BURL Employee Stock Option (right to buy) 15 Nov 2023 Common Stock 1,253 $121.35 Direct F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes restricted stock units for (i) 171 shares, which fully vest on May 1, 2024, (ii) 202 shares, which vest in equal installments on May 3 of each of 2024 and 2025, (iii) 554 shares, which vest in substantially equal installments on May 2 of each of 2024 through 2026, (iv) 49 shares, which vest in substantially equal installments on February 1 of each of 2024 through 2027, (v) 1,034 shares, which vest in substantially equal installments on May 1 of each of 2024 through 2027, (vi) 1,808 shares, which fully vest on January 9, 2026 and (vii) 466 shares which vest in substantially equal installments on October 9 of each of 2024 through 2027.
F2 Options granted on May 1, 2018 that are fully exercisable.
F3 Options granted on May 1, 2019 that are fully exercisable.
F4 Options granted on May 1, 2020 that are exercisable as to approximately 67% of the shares and become fully exercisable on the fourth anniversary of the grant date.
F5 Options granted on May 3, 2021 that are exercisable as to 50% of the shares and become exercisable as to an additional 25% of the shares on each of third and fourth anniversaries of the grant date.
F6 Options granted on May 2, 2022 that are exercisable as to 25% of the shares and become exercisable as to an additional 25% of the shares on each of the second through the fourth anniversaries of the grant date.
F7 Options granted on February 1, 2023 that become exercisable in one-quarter installments on each of the first four anniversaries of the grant date.
F8 Options granted on May 1, 2023 that become exercisable in one-quarter installments on each of the first four anniversaries of the grant date.
F9 Options granted on October 9, 2023 that become exercisable in one-quarter installments on each of the first four anniversaries of the grant date.

Remarks:

Exhibit 24 Power of Attorney